Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multikine + SOC in Advanced Primary Oral Squamous Cell Carcinoma
NCT01265849Phase 3Completed
- Sponsor
- CEL-SCI Corporation
- Start
- Dec 2010
- Primary completion
- May 2020
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Cytokines & Interferons
- Countries
- 23
01
Overview
A Phase 3 trial of leukocyte interleukin in squamous cell carcinoma of the oral cavity (OSCC), squamous cell carcinoma of the soft palate, sponsored by CEL-SCI Corporation. Started Dec 2010; status: completed.
02
Drugs
leukocyte interleukin
03
Conditions
squamous cell carcinoma of the oral cavity (OSCC)squamous cell carcinoma of the soft palate
Beyond the preview
Go deeper on NCT01265849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265849.